Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sertoli cell transfer restores sperm production in infertile mice

18.11.2002


Scientists at the University of Pennsylvania School of Veterinary Medicine have successfully transplanted specialized cells that are critical to sperm development in mice, restoring sperm production in once-infertile animals.

The research, reported on the Web site of the journal Biology of Reproduction, may give scientists a better understanding of how Sertoli cells -- which surround spermatogenic stem cells -- nourish sperm production and the survival of stem cells.

"Spermatogenesis is a highly organized process, requiring just the right environment, or ’niche,’ around the germ line stem cells," said Ralph L. Brinster, professor of reproductive physiology at Penn. "The Sertoli cells are essential to this environment, and it appears that by replacing them, we can essentially reconstruct the niche in which sperm development takes place."



Much of the volume of a mammalian testis consists of tightly coiled seminiferous tubules that hold mature sperm. Sperm development also occurs within these tubules, which are home to spermatogenic stem cells, the seeds from which spermatogenesis arises. Seminiferous tubules are lined with Sertoli cells, which are thought to nurture sperm cells as they develop and facilitate their eventual passage out of the testis.

Brinster and colleagues worked with Steel mutant mice, which are congenitally infertile due to a Sertoli cell defect. Before inserting healthy Sertoli cells, the researchers treated the mice’s testes with busulfan and cadmium to remove any defective germ cells and Sertoli cells. The seminiferous tubules remained, likely providing the structural support needed to completely reconstitute spermatogenesis from donor cells.

The Brinster group’s technique for transplanting Sertoli cells will likely allow scientists to study stem cells’ specialized environment in a way that has not been possible before. Currently, the best-studied stem cells are those that generate blood cells, even though these cells, which reside in bone marrow, are relatively inaccessible to researchers.

"I believe Dr. Brinster’s new results have catapulted the spermatogenic stem cell system into a position of maximum experimental flexibility among all other stem cell systems in the body," said John R. McCarrey, professor of cell and molecular biology at the University of Texas at San Antonio, who was not involved in this work. "This may lead to significant new insight into the manner in which the spermatogenic stem cell works in particular as well as to additional information about how all stem cells work in general."

Brinster’s work could eventually prove useful in the treatment of certain types of infertility in men, although complete spermatogenesis was established in only 1.5 to 3 percent of seminiferous tubules in this experiment.

"Male infertility can be caused either by defective germ cells or by a testicular environment that fails to promote proper spermatogenesis," Brinster said. "While several assisted reproductive technologies, such as in vitro fertilization or intracytoplasmic sperm injection, are now available for patients with low sperm counts, infertile patients with Sertoli cell defects have limited options."

The technique developed by Brinster and his colleagues may provide a new way of replacing defective Sertoli cells with healthy ones, which may initiate normal spermatogenesis in some infertile patients.


Brinster was joined in the research by Takashi Shinohara, now at Kyoto University, and Kyle E. Orwig and Mary R. Avarbock in Penn’s School of Veterinary Medicine. The work was funded by the Japan Society for Promotion of Science, the National Institute of Child Health and Human Development, the Commonwealth and General Assembly of Pennsylvania and the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation.


Steve Bradt | EurekAlert!
Further information:
http://www.upenn.edu/

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>